Abbott To Spin Off Nutrition Business Into Independent Public Company With $8.5B In Annual Sales; Separation Expected To Be Completed By 2027 End
Benzinga Newsdesk 1 week ago
NewsM&A
Separation will unlock potential of both companies to pursue distinct growth and value-creation strategiesThe new Nutrition company will be a global leader in the rapidly growing healthy nutrition market, with a
- Separation will unlock potential of both companies to pursue distinct growth and value-creation strategies
- The new Nutrition company will be a global leader in the rapidly growing healthy nutrition market, with a portfolio of iconic, category-leading brands, including Similac, PediaSure, Pedialyte, Glucerna and Ensure
- Abbott will have accelerated sales growth and an expanded margin profile
- Abbott intends to separate its Nutrition business through a tax-free distribution to Abbott shareholders
- Separation expected to be completed by the end of 2027
ABBOTT PARK, Ill., Oct. 21, 2026 /PRNewswire/ -- Abbott (NYSE:ABT), the global healthcare leader, today announced its intention to separate its Nutrition business into an independent, publicly traded company that will be a global leader in the rapidly expanding healthy nutrition market with approximately $8.5 billion in annual sales and a portfolio of iconic brands.